Evidence Review
Blood Pressure — Randomized Controlled Trials
The most influential single trial is a 6-week double-blind RCT by McKay et al. (2010) conducted at Tufts University [1]. Sixty-five pre-hypertensive and mildly hypertensive adults (aged 30–70) were randomized to three cups of hibiscus tea per day or a placebo beverage matched for appearance and taste. Systolic blood pressure fell by 7.2 mmHg in the hibiscus group versus 1.3 mmHg in placebo (P = 0.030). Diastolic blood pressure also declined, and the effect was most pronounced in participants with the highest baseline systolic readings. No adverse effects were reported.
Meta-Analyses of Blood Pressure Effects
Serban et al. (2015) pooled data from five RCTs in a meta-analysis and found that hibiscus supplementation significantly reduced both systolic blood pressure (weighted mean difference: −7.58 mmHg, 95% CI −9.69 to −5.46) and diastolic blood pressure (−3.53 mmHg, 95% CI −5.16 to −1.89) compared to controls [2]. Effect sizes were largest in trials of shorter duration and in participants with baseline systolic pressure above 130 mmHg.
A more recent and comprehensive 2022 meta-analysis by Herranz-López et al., drawing on 26 RCTs and 1,797 participants, confirmed these findings and noted a dose-dependent relationship — more cups per day and higher total anthocyanin content correlated with larger blood pressure reductions [4]. The authors noted high heterogeneity between trials (I² = 95% for some analyses), reflecting variability in hibiscus preparations, dosing, and participant characteristics, which limits confident quantification of the exact effect size.
Lipid and Metabolic Effects
Evidence for lipid-lowering is less consistent. A 2013 systematic review of eight trials examining serum lipids found mixed results — some trials showed reductions in total cholesterol and LDL, while others showed no significant change versus placebo [5]. The authors concluded that while hibiscus shows antioxidant activity that could theoretically benefit lipid profiles, the human trial evidence for direct lipid lowering is not robust enough to support a firm clinical recommendation.
Hopkins et al. (2013) reviewed both animal and human data across hypertension and hyperlipidemia [3]. Animal models consistently showed lipid-lowering and antihypertensive effects, and human trials were supportive for blood pressure but more equivocal for lipids. They noted that preparation method (water extract vs. concentrated extract), anthocyanin content of the specific plant material, and study duration all complicate cross-study comparisons.
Overall Strength of Evidence
For blood pressure in pre-hypertensive and stage 1 hypertensive adults, the evidence is reasonably strong: multiple RCTs and several meta-analyses consistently show modest but meaningful reductions in systolic blood pressure (typically 5–10 mmHg). The mechanism is plausible and the effect size is clinically relevant — comparable to modest dietary interventions like the DASH diet or reducing sodium intake. For LDL cholesterol and triglycerides, the evidence remains inconclusive. As a low-risk, caffeine-free beverage with good safety data at typical tea-drinking doses, hibiscus is a reasonable addition to a cardiovascular-supportive lifestyle, especially for adults managing mildly elevated blood pressure.